欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号EE/H/0307/002
药品名称Apixaban Viatris
活性成分
    • APIXABAN 5.0 mg
剂型Film-coated tablet
上市许可持有人Viatris Limited Damastown Industrial Park, Mulhuddart Dublin 15 Ireland
参考成员国 - 产品名称Estonia (EE)
Apixaban Viatris
互认成员国 - 产品名称
    • Latvia (LV)
      Apixaban Mylan 5 mg apvalkotās tabletes
    • Iceland (IS)
      Apixaban Mylan 5 mg Filmuhúðuð tafla
    • Lithuania (LT)
      Apixaban Mylan 5 mg plėvele dengtos tabletės
    • Ireland (IE)
    • Hungary (HU)
    • Austria (AT)
      Apixaban Mylan 5 mg Filmtabletten
    • Bulgaria (BG)
      Apixaban Mylan
    • France (FR)
    • Cyprus (CY)
      Apixaban Mylan 5 mg film coated tablets
    • Spain (ES)
    • Czechia (CZ)
      Apixaban Mylan
    • Portugal (PT)
    • Slovakia (SK)
    • Italy (IT)
    • Malta (MT)
    • Germany (DE)
      Apixaban Mylan 5 mg Filmtabletten
    • Greece (GR)
    • Denmark (DK)
    • Sweden (SE)
    • Belgium (BE)
      Apixaban Viatris 5 mg filmomhulde tabletten
    • Norway (NO)
    • Netherlands (NL)
    • Finland (FI)
    • Luxembourg (LU)
许可日期2021/05/17
最近更新日期2024/04/05
药物ATC编码
    • B01AF02 apixaban
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase